Comorbid depression in medical diseases.
Stefan M Gold1,2,3, Ole Köhler-Forsberg4,5,6, Rona Moss-Morris7
1Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt Universität zu Berlin, Berlin Institute of Health (BIH), Klinik für Psychiatrie und Psychotherapie, Campus Benjamin Franklin, Berlin, Germany. stefan.gold@charite.de.
Nature Reviews. Disease Primers
|August 22, 2020
Summary
Depression frequently co-occurs with chronic medical conditions, increasing patient burden. Integrated care plans are vital for managing depression alongside physical illnesses.
Area of Science:
- Medical Science
- Psychiatry
- Public Health
Background:
- Depression is a common comorbidity in chronic medical diseases like cancer and cardiovascular disorders.
- Its prevalence is higher in these patient groups, contributing significantly to psychosocial burden.
- Factors include shared genetics, biological pathways, social, behavioral, and psychological elements.
Purpose of the Study:
- To review the challenges and considerations in managing comorbid depression in patients with chronic medical conditions.
- To highlight the need for tailored treatment approaches.
Main Methods:
- Literature review and synthesis of existing research on depression in chronic illness.
- Analysis of diagnostic challenges and treatment modifications.
Main Results:
- Symptomatic overlap between depression and medical disorders complicates diagnosis.
- Treatments for medical conditions can interfere with depression management, and vice versa.
- Depression can reduce adherence to treatment for both conditions.
Conclusions:
- Comprehensive, integrated treatment plans are essential for optimizing care in patients with comorbid depression and medical disorders.
- Adjustments to standard treatments are often necessary.
- Addressing the interplay between physical and mental health is crucial.
Related Concept Videos
01:27Depressive Disorders: MDD and Dysthymia
402
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
402
01:27Depressive Disorders: Etiology
331
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
331
01:18Depression: Overview
630
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
630
01:23Antidepressant Drugs: MAOIs and Other Agents
663
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
663
01:25Antidepressant Drugs: Overview
1.2K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.2K
01:03Long-term Depression
2.9K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.9K